Home›Companies›Biotech & Pharma›ANGELIS Oncology

Angelis Oncology, Inc.

Develops an investigational drug for people with hard-to-treat brain and nervous system cancers.

Updated Nov 10, 2026·Latest SEC filing Jul 23, 2026·Suggest an edit

About ANGELIS Oncology

ANGELIS Oncology is a private company based in San Francisco, California, incorporated in 2026 in Delaware. It has reported $400,000 raised in one offering on Form D since July 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 10, 2026Jul 23, 2026$400,000target not set1$400KDebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ANGELIS Oncology's Form D filed Jul 23, 2026.

DS
Daniel Santi
Founder and Member of the Board

Sources

  1. SECAngelis Oncology, Inc. filing history
  2. CompanyAbout Angelis Oncology
  3. CompanyAngelis Oncology team